概括
对于阿片类药物使用障碍 (OUD) 患者来说,从芬太尼或甲等强效阿片类药物过渡到布普伦诺芬可能具有挑战性. 使用全激动剂和非阿片类药物的新策略在几天内缓解了这种过渡.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 患者护理 患者护理
背景情况:
- 删除X豁免增加了阿片类药物使用障碍 (OUD) 患者获得布普伦诺芬的机会.
- 从高强度阿片类药物 (芬太尼,甲) 转换为布普伦诺芬的患者经常面临重大挑战.
- OUD治疗需要药物辅助治疗过渡的有效策略.
研究的目的:
- 描述一种新的策略,用于将阿片类药物使用障碍 (OUD) 的患者从高剂量甲或大量芬太尼使用过渡到布普伦诺芬.
- 介绍一个从住院患者的临床经验中开发的非正式协议.
- 为了促进更顺,更舒适的过渡到布普伦诺芬治疗.
主要方法:
- 在开始低剂量布普伦诺芬诱导期间使用全激动剂.
- 实施灵活的低剂量布普伦诺芬诱导策略.
- 用非阿片类药物辅助药物来管理戒断和不适症状.
主要成果:
- 描述的策略支持成功从高强度阿片类药物过渡到布普伦诺芬.
- 协议允许在几天的时间内进行过渡.
- 临床经验表明,这种方法可以缓解与阿片类药物过渡相关的挑战.
结论:
- 将患者从大量芬太尼或高剂量甲转换为布普伦诺芬在几天内是可行的.
- 仔细监测患者的症状对于成功过渡至关重要.
- 谨慎使用短效阿片类药物和非阿片类辅助药物是管理戒断和确保患者舒适的关键.
相关概念视频
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
246
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
246
01:25Analgesia and Pain Management
551
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
551
01:20Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
192
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
01:22Opioid Receptors: Overview
584
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
584